TherapeuticsMD Announces Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
TherapeuticsMD (TXMD) Tops Q3 EPS by 5c
November 7, 2018 4:53 PM ESTTherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.16), $0.05 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.43 million.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More